Solid-phase synthesis of a pentavalent GalNAc-containing glycopeptide (Tn antigen) representing the nephropathy-associated IgA hinge region

J.G.M. Bolscher, J. Brevoord, K. Nazmi, T. Ju, E.C.I. Veerman, J.A.E. van Wijk, R.D. Cummings, I. van Die

Research output: Contribution to journalArticleAcademicpeer-review

12 Citations (Scopus)

Abstract

Incomplete or aberrant glycosylation leading to Tn antigen (GalNAca1-Ser/Thr) expression on human glycoproteins is strongly associated with human pathological conditions, including tumors, certain autoimmune diseases, such as the idiopathic IgA nephropathy, and may modulate immune homeostasis. In addition, the Tn antigen is highly expressed by certain pathogens and plays a role in host-pathogen interactions.
To enable experimental approaches to study interactions of the Tn antigen with the immune system and analyze anti-Tn antibody responses in infection or disorders, we generated a Tn-expressing resource that can be used for high-throughput screening. In consideration of IgA nephropathy in which the hinge region is incompletely glycosylated, we used this hinge sequence that encodes five potential glycosylation sites as the ideal template for the synthesis of a Tn antigen-expressing glycopeptide. Inclusion of an N-terminal biotin in the peptide enabled binding to streptavidin-coated ELISA plates as monitored using Helix pomatia agglutinin or anti-Tn monoclonal antibody. We also found that the biotinylated IgA-Tn peptide is a functional acceptor for b1-3-galactosylation using recombinant T-synthase (b1-3-galactosyltransferase). Besides its immunochemical functionality as a possible diagnostic tool for IgA nephropathy, the peptide is an excellent substrate for glycan elongation and represents a novel template applicable for glycan-antigen-associated diseases.
Original languageEnglish
Pages (from-to)1998-2003
JournalCarbohydrate Research
Volume345
Issue number14
DOIs
Publication statusPublished - 2010

Cite this